Trial Profile
Clinical Trials Insight: 700056970
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jun 2010
Price :
$35
*
At a glance
- Drugs TRC 093 (Primary) ; Bevacizumab
- Indications Glioblastoma
- Focus Therapeutic Use
- 16 Jun 2010 New trial record